HEADER HYDROLASE 02-JUN-16 5L77 TITLE A GLYCOSIDE HYDROLASE MUTANT WITH AN UNREACTED ACTIVITY BASED PROBE TITLE 2 BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-GLUCURONIDASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ACIDOBACTERIUM CAPSULATUM; SOURCE 3 ORGANISM_TAXID: 33075; SOURCE 4 GENE: ACP_2665; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.JIN,L.WU,J.B.JIANG,H.S.OVERKLEEFT,G.J.DAVIES REVDAT 5 23-OCT-19 5L77 1 COMPND FORMUL REVDAT 4 16-OCT-19 5L77 1 REMARK REVDAT 3 06-SEP-17 5L77 1 JRNL REVDAT 2 14-JUN-17 5L77 1 JRNL REVDAT 1 31-MAY-17 5L77 0 JRNL AUTH L.WU,J.JIANG,Y.JIN,W.W.KALLEMEIJN,C.L.KUO,M.ARTOLA,W.DAI, JRNL AUTH 2 C.VAN ELK,M.VAN EIJK,G.A.VAN DER MAREL,J.D.C.CODEE, JRNL AUTH 3 B.I.FLOREA,J.M.F.G.AERTS,H.S.OVERKLEEFT,G.J.DAVIES JRNL TITL ACTIVITY-BASED PROBES FOR FUNCTIONAL INTERROGATION OF JRNL TITL 2 RETAINING BETA-GLUCURONIDASES. JRNL REF NAT. CHEM. BIOL. V. 13 867 2017 JRNL REFN ESSN 1552-4469 JRNL PMID 28581485 JRNL DOI 10.1038/NCHEMBIO.2395 REMARK 2 REMARK 2 RESOLUTION. 1.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.6 REMARK 3 NUMBER OF REFLECTIONS : 120177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.131 REMARK 3 R VALUE (WORKING SET) : 0.129 REMARK 3 FREE R VALUE : 0.160 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6276 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.24 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.27 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4890 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 49.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.2550 REMARK 3 BIN FREE R VALUE SET COUNT : 242 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3457 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 483 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.28000 REMARK 3 B22 (A**2) : -1.49000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.26000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.037 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.038 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.028 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.480 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.979 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.970 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3626 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3305 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4949 ; 1.734 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7602 ; 1.059 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 467 ; 5.798 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 160 ;32.355 ;23.688 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 512 ;11.838 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;11.594 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 529 ; 0.115 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4208 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 861 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1841 ; 1.953 ; 1.600 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1842 ; 1.953 ; 1.600 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2302 ; 2.429 ; 2.416 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2303 ; 2.430 ; 2.417 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1785 ; 2.837 ; 1.906 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1785 ; 2.834 ; 1.905 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2640 ; 3.397 ; 2.769 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4642 ; 4.344 ;15.320 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4642 ; 4.344 ;15.318 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 6931 ; 2.685 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 106 ;32.156 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 7218 ;13.297 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5L77 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1200000239. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 126454 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.240 REMARK 200 RESOLUTION RANGE LOW (A) : 28.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3VYO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12 MG/ML PROTEIN STOCK IN MIXED 1:1 REMARK 280 WITH 1.2 M NAH2PO4/K2HPO4 (1:9 V/V) AT 293 K., PH 8.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 75.08500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.56000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 75.08500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.56000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 709 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PHE A 3 REMARK 465 ALA A 4 REMARK 465 ARG A 5 REMARK 465 GLY A 6 REMARK 465 GLY A 7 REMARK 465 LEU A 8 REMARK 465 ALA A 9 REMARK 465 GLN A 10 REMARK 465 THR A 11 REMARK 465 ALA A 12 REMARK 465 SER A 13 REMARK 465 GLN A 14 REMARK 465 THR A 15 REMARK 465 THR A 16 REMARK 465 SER A 17 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 92 CG CD CE NZ REMARK 470 ALA A 95 CB REMARK 470 ASP A 229 CG OD1 OD2 REMARK 470 ARG A 257 NE CZ NH1 NH2 REMARK 470 LYS A 369 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 284 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG A 392 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 392 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ASP A 403 CB - CG - OD1 ANGL. DEV. = 7.0 DEGREES REMARK 500 ARG A 420 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 219 -21.74 -158.99 REMARK 500 VAL A 299 -63.68 -129.70 REMARK 500 SER A 457 114.72 -32.51 REMARK 500 GLN A 459 83.31 -150.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1081 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A1082 DISTANCE = 6.35 ANGSTROMS REMARK 525 HOH A1083 DISTANCE = 7.22 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GUX A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 508 DBREF 5L77 A 1 475 UNP C1F2K5 C1F2K5_ACIC5 1 475 SEQADV 5L77 MET A -19 UNP C1F2K5 INITIATING METHIONINE SEQADV 5L77 GLY A -18 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 SER A -17 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 SER A -16 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A -15 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A -14 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A -13 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A -12 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A -11 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A -10 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 SER A -9 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 SER A -8 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 GLY A -7 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 LEU A -6 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 VAL A -5 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 PRO A -4 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 ARG A -3 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 GLY A -2 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 SER A -1 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 HIS A 0 UNP C1F2K5 EXPRESSION TAG SEQADV 5L77 GLN A 287 UNP C1F2K5 GLU 287 ENGINEERED MUTATION SEQRES 1 A 495 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 495 LEU VAL PRO ARG GLY SER HIS MET ALA PHE ALA ARG GLY SEQRES 3 A 495 GLY LEU ALA GLN THR ALA SER GLN THR THR SER SER PRO SEQRES 4 A 495 VAL ARG VAL GLY LEU SER VAL ASP ALA SER ALA LEU GLY SEQRES 5 A 495 HIS THR ILE PRO PRO ASP TYR THR GLY LEU SER TYR GLU SEQRES 6 A 495 GLN ALA GLN MET ALA ASN PRO ASN TYR PHE SER GLY ALA SEQRES 7 A 495 ASN THR GLN LEU ALA GLY PHE LEU ARG THR LEU GLY ARG SEQRES 8 A 495 GLN GLY VAL LEU ARG ILE GLY GLY ASN THR SER GLU TYR SEQRES 9 A 495 THR PHE TRP ASN ARG HIS ALA LYS PRO THR ALA ALA ASP SEQRES 10 A 495 GLU HIS LEU ALA ALA GLY PRO ASP LYS GLY HIS HIS ALA SEQRES 11 A 495 ALA ALA ARG GLU VAL ILE THR PRO GLU ALA VAL ASN ASN SEQRES 12 A 495 LEU SER GLU PHE LEU ASP LYS THR GLY TRP LYS LEU ILE SEQRES 13 A 495 TYR GLY LEU ASN LEU GLY LYS GLY THR PRO GLU ASN ALA SEQRES 14 A 495 ALA ASP GLU ALA ALA TYR VAL MET GLU THR ILE GLY ALA SEQRES 15 A 495 ASP ARG LEU LEU ALA PHE GLN LEU GLY ASN GLU PRO ASP SEQRES 16 A 495 LEU PHE TYR ARG ASN GLY ILE ARG PRO ALA SER TYR ASP SEQRES 17 A 495 PHE ALA ALA TYR ALA GLY ASP TRP GLN ARG PHE PHE THR SEQRES 18 A 495 ALA ILE ARG LYS ARG VAL PRO ASN ALA PRO PHE ALA GLY SEQRES 19 A 495 PRO ASP THR ALA TYR ASN THR LYS TRP LEU VAL PRO PHE SEQRES 20 A 495 ALA ASP LYS PHE LYS HIS ASP VAL LYS PHE ILE SER SER SEQRES 21 A 495 HIS TYR TYR ALA GLU GLY PRO PRO THR ASP PRO SER MET SEQRES 22 A 495 THR ILE GLU ARG LEU MET LYS PRO ASN PRO ARG LEU LEU SEQRES 23 A 495 GLY GLU THR ALA GLY LEU LYS GLN VAL GLU ALA ASP THR SEQRES 24 A 495 GLY LEU PRO PHE ARG LEU THR GLN THR ASN SER CYS TYR SEQRES 25 A 495 GLN GLY GLY LYS GLN GLY VAL SER ASP THR PHE ALA ALA SEQRES 26 A 495 ALA LEU TRP ALA GLY ASP LEU MET TYR GLN GLN ALA ALA SEQRES 27 A 495 ALA GLY SER THR GLY ILE ASN PHE HIS GLY GLY GLY TYR SEQRES 28 A 495 GLY TRP TYR THR PRO VAL ALA GLY THR PRO GLU ASP GLY SEQRES 29 A 495 PHE ILE ALA ARG PRO GLU TYR TYR GLY MET LEU LEU PHE SEQRES 30 A 495 ALA GLN ALA GLY ALA GLY GLN LEU LEU GLY ALA LYS LEU SEQRES 31 A 495 THR ASP ASN SER ALA ALA PRO LEU LEU THR ALA TYR ALA SEQRES 32 A 495 LEU ARG GLY THR ASP GLY ARG THR ARG ILE ALA LEU PHE SEQRES 33 A 495 ASN LYS ASN LEU ASP ALA ASP VAL GLU VAL ALA ILE SER SEQRES 34 A 495 GLY VAL ALA SER PRO SER GLY THR VAL LEU ARG LEU GLU SEQRES 35 A 495 ALA PRO ARG ALA ASP ASP THR THR ASP VAL THR PHE GLY SEQRES 36 A 495 GLY ALA PRO VAL GLY ALA SER GLY SER TRP SER PRO LEU SEQRES 37 A 495 VAL GLN GLU TYR VAL PRO GLY HIS SER GLY GLN PHE VAL SEQRES 38 A 495 LEU HIS MET ARG LYS ALA SER GLY ALA LEU LEU GLU PHE SEQRES 39 A 495 ALA HET PO4 A 501 5 HET PO4 A 502 5 HET PO4 A 503 5 HET PO4 A 504 5 HET PO4 A 505 5 HET GUX A 506 24 HET CL A 507 1 HET GOL A 508 6 HETNAM PO4 PHOSPHATE ION HETNAM GUX (1~{R},2~{S},3~{R},4~{S},5~{S},6~{R})-7-[8- HETNAM 2 GUX [(AZANYLIDENE-{4}-AZANYLIDENE)AMINO]OCTYL]-3,4,5- HETNAM 3 GUX TRIS(OXIDANYL)-7-AZABICYCLO[4.1.0]HEPTANE-2-CARBOXYLIC HETNAM 4 GUX ACID HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 PO4 5(O4 P 3-) FORMUL 7 GUX C15 H26 N4 O5 FORMUL 8 CL CL 1- FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *483(H2 O) HELIX 1 AA1 ALA A 47 ASN A 51 5 5 HELIX 2 AA2 ASN A 59 GLY A 70 1 12 HELIX 3 AA3 GLY A 79 GLU A 83 5 5 HELIX 4 AA4 ALA A 96 LEU A 100 5 5 HELIX 5 AA5 THR A 117 GLY A 132 1 16 HELIX 6 AA6 THR A 145 GLY A 161 1 17 HELIX 7 AA7 GLU A 173 ASP A 175 5 3 HELIX 8 AA8 LEU A 176 GLY A 181 1 6 HELIX 9 AA9 ASP A 188 VAL A 207 1 20 HELIX 10 AB1 ASN A 220 LYS A 222 5 3 HELIX 11 AB2 TRP A 223 LYS A 232 1 10 HELIX 12 AB3 THR A 254 MET A 259 1 6 HELIX 13 AB4 ASN A 262 GLY A 280 1 19 HELIX 14 AB5 THR A 302 ALA A 319 1 18 HELIX 15 AB6 ARG A 348 GLY A 361 1 14 HELIX 16 AB7 GLY A 440 SER A 444 5 5 SHEET 1 AA1 3 THR A 433 PHE A 434 0 SHEET 2 AA1 3 GLY A 416 GLU A 422 -1 N GLU A 422 O THR A 433 SHEET 3 AA1 3 GLU A 451 TYR A 452 -1 O GLU A 451 N VAL A 418 SHEET 1 AA210 THR A 433 PHE A 434 0 SHEET 2 AA210 GLY A 416 GLU A 422 -1 N GLU A 422 O THR A 433 SHEET 3 AA210 SER A 468 PHE A 474 -1 O GLY A 469 N LEU A 421 SHEET 4 AA210 THR A 391 ASN A 397 -1 N ILE A 393 O LEU A 472 SHEET 5 AA210 LEU A 379 GLY A 386 -1 N TYR A 382 O ALA A 394 SHEET 6 AA210 GLY A 363 THR A 371 -1 N GLN A 364 O ARG A 385 SHEET 7 AA210 VAL A 20 ILE A 35 -1 N ILE A 35 O GLY A 363 SHEET 8 AA210 VAL A 404 SER A 409 1 O ALA A 407 N VAL A 22 SHEET 9 AA210 GLN A 459 MET A 464 -1 O LEU A 462 N VAL A 406 SHEET 10 AA210 GLY A 455 HIS A 456 -1 N HIS A 456 O GLN A 459 SHEET 1 AA3 8 LEU A 165 LEU A 170 0 SHEET 2 AA3 8 LYS A 134 LEU A 139 1 N TYR A 137 O ALA A 167 SHEET 3 AA3 8 VAL A 74 GLY A 78 1 N LEU A 75 O LYS A 134 SHEET 4 AA3 8 GLY A 41 GLU A 45 1 N LEU A 42 O ARG A 76 SHEET 5 AA3 8 ILE A 324 GLY A 328 1 O PHE A 326 N SER A 43 SHEET 6 AA3 8 PHE A 283 ASN A 289 1 N THR A 288 O HIS A 327 SHEET 7 AA3 8 PHE A 237 TYR A 243 1 N ILE A 238 O ARG A 284 SHEET 8 AA3 8 ALA A 213 THR A 217 1 N THR A 217 O HIS A 241 SHEET 1 AA4 2 THR A 85 TRP A 87 0 SHEET 2 AA4 2 GLU A 114 ILE A 116 1 O GLU A 114 N PHE A 86 SHEET 1 AA5 2 VAL A 337 THR A 340 0 SHEET 2 AA5 2 GLY A 344 ALA A 347 -1 O ILE A 346 N ALA A 338 CISPEP 1 GLY A 214 PRO A 215 0 4.66 SITE 1 AC1 4 HIS A 33 THR A 34 HOH A 626 HOH A 775 SITE 1 AC2 4 TRP A 333 HOH A 609 HOH A 668 HOH A 862 SITE 1 AC3 5 ASN A 148 HOH A 601 HOH A 708 HOH A 774 SITE 2 AC3 5 HOH A 893 SITE 1 AC4 5 ARG A 420 GLU A 422 HIS A 463 MET A 464 SITE 2 AC4 5 ARG A 465 SITE 1 AC5 9 GLY A 103 LYS A 106 GLY A 330 TYR A 331 SITE 2 AC5 9 GLY A 332 HOH A 605 HOH A 640 HOH A 718 SITE 3 AC5 9 HOH A 953 SITE 1 AC6 16 GLU A 45 GLY A 79 ASN A 80 PRO A 104 SITE 2 AC6 16 ASP A 105 ASN A 172 GLU A 173 LEU A 176 SITE 3 AC6 16 TYR A 243 GLN A 287 TYR A 292 GLN A 293 SITE 4 AC6 16 GLY A 294 HIS A 327 TYR A 334 HOH A 664 SITE 1 AC7 2 HIS A 33 LYS A 273 SITE 1 AC8 4 HIS A 108 HIS A 109 HOH A 621 HOH A 839 CRYST1 150.170 45.120 82.040 90.00 115.11 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006659 0.000000 0.003121 0.00000 SCALE2 0.000000 0.022163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013461 0.00000 MASTER 395 0 8 16 25 0 15 6 0 0 0 39 END